Detalhe da pesquisa
1.
EHMT2/G9a and EZH2: Epimarkers in testicular germ cell tumors.
Andrology
; 2024 Feb 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-38380739
2.
Novel Insights on the Role of Epigenetics in Androgen Receptor's Expression in Prostate Cancer.
Biomolecules
; 13(10)2023 10 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37892208
3.
From Therapy Resistance to Targeted Therapies in Prostate Cancer.
Front Oncol
; 12: 877379, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35686097
4.
G9a inhibition by CM-272: Developing a novel anti-tumoral strategy for castration-resistant prostate cancer using 2D and 3D in vitro models.
Biomed Pharmacother
; 150: 113031, 2022 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-35483199
5.
Epigenetically-regulated miR-30a/c-5p directly target TWF1 and hamper ccRCC cell aggressiveness.
Transl Res
; 249: 110-127, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-35697274
6.
Hydralazine and Panobinostat Attenuate Malignant Properties of Prostate Cancer Cell Lines.
Pharmaceuticals (Basel)
; 14(7)2021 Jul 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-34358096
7.
Repurposing Old Drugs into New Epigenetic Inhibitors: Promising Candidates for Cancer Treatment?
Pharmaceutics
; 12(5)2020 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-32365701